Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment

Denisa Muraru,Luigi P Badano,Rebecca T Hahn,Roberto M Lang,Victoria Delgado,Nina C Wunderlich,Erwan Donal,Maurizio Taramasso,Alison Duncan,Philipp Lurz,Tom De Potter,José L Zamorano Gómez,Jeroen J Bax,Ralph Stephan von Bardeleben,Maurice Enriquez-Sarano,Francesco Maisano,Fabien Praz,Marta Sitges

DOI: https://doi.org/10.1093/eurheartj/ehae088

IF: 39.3

2024-03-06

European Heart Journal

Abstract:Atrial secondary tricuspid regurgitation (A-STR) is a distinct phenotype of secondary tricuspid regurgitation with predominant dilation of the right atrium and normal right and left ventricular function. Atrial secondary tricuspid regurgitation occurs most commonly in elderly women with atrial fibrillation and in heart failure with preserved ejection fraction in sinus rhythm. In A-STR, the main mechanism of leaflet malcoaptation is related to the presence of a significant dilation of the tricuspid annulus secondary to right atrial enlargement. In addition, there is an insufficient adaptive growth of tricuspid valve leaflets that become unable to cover the enlarged annular area. As opposed to the ventricular phenotype, in A-STR, the tricuspid valve leaflet tethering is typically trivial. The A-STR phenotype accounts for 10%–15% of clinically relevant tricuspid regurgitation and has better outcomes compared with the more prevalent ventricular phenotype. Recent data suggest that patients with A-STR may benefit from more aggressive rhythm control and timely valve interventions. However, little is mentioned in current guidelines on how to identify, evaluate, and manage these patients due to the lack of consistent evidence and variable definitions of this entity in recent investigations. This interdisciplinary expert opinion document focusing on A-STR is intended to help physicians understand this complex and rapidly evolving topic by reviewing its distinct pathophysiology, diagnosis, and multi-modality imaging characteristics. It first defines A-STR by proposing specific quantitative criteria for defining the atrial phenotype and for discriminating it from the ventricular phenotype, in order to facilitate standardization and consistency in research.

cardiac & cardiovascular systems

What problem does this paper attempt to address?

The paper attempts to address issues related to the pathophysiology, definition, diagnosis, and treatment of atrial secondary tricuspid regurgitation (A-STR). Specifically, the paper aims to:

1. **Clarify the pathophysiological mechanisms of A-STR**: Explain that the primary mechanism of A-STR is significant dilation of the right atrium and tricuspid annulus, leading to the tricuspid leaflets being unable to fully cover the enlarged annular area, thereby causing regurgitation.

2. **Propose a standardized definition of A-STR**: Define A-STR through specific quantitative criteria and distinguish it from the more common ventricular secondary tricuspid regurgitation (V-STR) to promote consistency and standardization in research.

3. **Provide diagnostic and multimodal imaging characteristics**: Detail the diagnostic methods and imaging features of A-STR, including specific measurement parameters and considerations for both 2D and 3D echocardiography.

4. **Explore clinical management and treatment strategies for A-STR**: Discuss how to identify, evaluate, and manage patients with A-STR, particularly emphasizing the potential clinical benefits of timely rhythm control and valvular intervention.

The paper also points out that current guidelines lack consistent evidence and clear guidance for the identification, evaluation, and treatment of A-STR, indicating a need for further research to optimize treatment strategies for this specific type of tricuspid regurgitation.